These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2596239)

  • 1. Cytochemical detection of nickel in endometrial carcinoma during progestogen treatment.
    Patai K; Szarvas Z; Balogh I
    Acta Chir Hung; 1989; 30(3):199-204. PubMed ID: 2596239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gestagen treatment of endometrial carcinoma].
    Seewald HJ; Böhm W
    Zentralbl Gynakol; 1974 Feb; 96(5):153-7. PubMed ID: 4133105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 4. [Histological changes observed in the treatment of endometrial glandular epithelioma with lynestrenol].
    Lejeune B; Wilkin P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Dec; 6(8):1159-69. PubMed ID: 608932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of endocrine therapy of endometrial carcinoma].
    Kuramoto H; Hata H; Kato Y; Hata K; Hamano M; Anzai Y; Watanabe J; Holinka CF; Gurpide E
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1851-7. PubMed ID: 2730078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with high doses of progestational agents in endometrial adenocarcinoma].
    Goisis M; Servida E; Goisis F
    Minerva Ginecol; 1976 Jan; 28(1):87-96. PubMed ID: 1256709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
    Miyawaki Y; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progestational hormones in endometrial carcinoma].
    Corres Innes J; Zazueta Valadez F; Vela Lugo C
    Ginecol Obstet Mex; 1967 Sep; 22(131):1193-203. PubMed ID: 5602498
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of progestogen therapy with the conventional treatment of endometrial carcinoma.
    Luukkainen T; Karjalainen O
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):581-5. PubMed ID: 5510182
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral progestogens and adenocarcinoma of the uterus. An account of 3 cases of advanced endometrial carcinoma treated with an oral progestogen.
    Phillips TJ
    J Obstet Gynaecol Br Commonw; 1966 Jun; 73(3):487-9. PubMed ID: 5947437
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simultaneous cytofluorometric studies on DNA and protein in endometrial adenocarcinoma--with reference to gestagen treatment].
    Ohta T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):750-8. PubMed ID: 3722954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gestagen treatment of endometrial carcinoma--theoretical and practical application].
    Sugawa T; Sako H
    Gan To Kagaku Ryoho; 1984 May; 11(5):1005-11. PubMed ID: 6721511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment.
    Edmonson JH; Krook JE; Hilton JF; Long HJ; Cullinan SA; Everson LK; Malkasian GD
    Cancer Treat Rep; 1986 Aug; 70(8):1019-20. PubMed ID: 3731147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
    Vecchione A; Ruozi Berretta L
    Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of estrogen receptor levels in endometrial cancer cells.
    Gurpide E; Blumenthal R; Fleming H
    Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of an estrogen-regulated protein in endometrial cancer.
    Sledge GW; Ramzy I; Dressler LG; Dorr FA; Adams DJ; McGuire WL
    Obstet Gynecol; 1985 Sep; 66(3):423-7. PubMed ID: 3895080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathological changes in endometrial cancer treated with tamoxifen].
    Lin HH; Ueda K; Kato J
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1038-43. PubMed ID: 3963849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen in recurrenct endometrial carcinoma.
    Mehta A; Shroff M
    Indian J Cancer; 1966 Dec; 3(4):305-9. PubMed ID: 5977884
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
    Billiet G; De Hertogh R; Bonte J; Ide P; Vlaemynck G
    Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
    Hatae M; Yagi Y
    Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.